Wordt geladen...
FGFR1 is critical for RBL2 loss-driven tumor development and requires PLCG1 activation for continued growth of small cell lung cancer
Small cell lung cancer (SCLC) remains a recalcitrant disease where limited therapeutic options have not improved overall survival and approved targeted therapies are lacking. Amplification of the tyrosine kinase receptor FGFR1 (fibroblast growth factor receptor 1) is one of the few actionable altera...
Bewaard in:
| Gepubliceerd in: | Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7669587/ https://ncbi.nlm.nih.gov/pubmed/32973083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-20-1453 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|